Close Menu

NEW YORK (GenomeWeb) – The University of Texas MD Anderson Cancer Center said this week that it has been awarded more than $22 million in research grants from the Cancer Prevention and Research Institute of Texas (CPRIT), including several awards for omics-related projects.

Across Texas institutions, CPRIT awarded a total of 73 new grants worth a cumulative $112 million. MD Anderson's CPRIT awards included $14.8 million for research, $6 million in recruitment funding, and $1.4 million for evidence-based cancer prevention services.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by
Sophia Genetics

This webinar will share the Lorraine Cancer Institute's experience in implementing a novel targeted solution to accurately assess homologous recombination repair (HRR) deficiency by analyzing a series of genes, beyond BRCA, and calling multiple types of variants, including copy number variants (CNVs).

Sponsored by
LGC SeraCare Life Sciences

This webinar features a panel of industry stakeholders in cancer diagnostics, proficiency testing and clinical care who will discuss the promise and challenges of liquid biopsy technologies in disease diagnosis, monitoring, and patient care management.

Sponsored by

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

Sponsored by

Molecular tumor profiling has provided extensive value, both in tumor biology and oncology, with the development of new technologies to identify biomarkers.